MBiotech Program News

04/04/2012 - 14:00 - MBiotech students shortlisted in international essay competition

A team of three Master of Biotechnology students were were recently short-listed in an international essay competition sponsored by GlaxoSmithKline.  The GSK Rare Diseases competition invited views, insights and business strategies on the subject "Rare Diseases: a sustainable model for the pharmaceutical industry." Submissions...

30/03/2012 - 09:00 - Dr. Leigh Revers presents to the European Association of Hospital Pharmacists

On Thursday, March 22, Dr. Leigh Revers, Associate Director of the Master of Biotechnology Program, presented to the European Association of Hospital Pharmacists Symposium in Milan, Italy. The title of his talk was "Monocolonal antibodies: What makes them unique?"

15/03/2012 - 10:00 - MBiotech Team Places 2nd in Venture Capital Competition

Students from the Master of Biotechnology Program have once again produced outstanding results in the latest Venture Capital & Innovation Competition (VCIC), placing second against Rotman MBA teams. VCIC is the world’s premiere educational strategy competition for venture-minded and entrepreneurial MBA students in which the goal is...

06/02/2012 - 08:30 - MBiotech launches new website

The Master of Biotechnology Program launched a new website this morning, in conjunction with the launch of the new website for the University of Toronto Mississauga.  Over the last year, a comprehensive overhaul of UTM’s website has been underway with the goal to make the user experience intuitive, fast and successful. Using...

02/02/2012 - 15:00 - Dr. Leigh Revers presents to Breast Cancer Oncologists

Dr. Leigh Revers, Associate Director of the Master of Biotechnology Program, presented to breast cancer oncologists from across Canada this evening. The title of his presentation was "The Role and Implication of Subsequent Entry Biologics (SEBs) in the Treatment of HER2+ Breast Cancer Patients in Canada".    

Pages